Two Sigma Advisers LP raised its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 54.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 157,300 shares of the health services provider's stock after purchasing an additional 55,700 shares during the quarter. Two Sigma Advisers LP owned approximately 0.28% of Maximus worth $11,742,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank bought a new position in Maximus during the 4th quarter valued at about $71,443,000. SG Capital Management LLC bought a new position in shares of Maximus in the 4th quarter worth approximately $30,285,000. Federated Hermes Inc. lifted its stake in shares of Maximus by 74.8% in the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock worth $65,912,000 after purchasing an additional 377,705 shares during the period. AQR Capital Management LLC lifted its stake in shares of Maximus by 189.1% in the 4th quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock worth $31,599,000 after purchasing an additional 276,859 shares during the period. Finally, Marshall Wace LLP lifted its stake in shares of Maximus by 1,319.1% in the 4th quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider's stock worth $16,742,000 after purchasing an additional 208,463 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Get Our Latest Report on MMS
Insider Activity at Maximus
In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.
Maximus Price Performance
Shares of MMS stock traded down $1.32 on Wednesday, reaching $73.38. The company's stock had a trading volume of 65,322 shares, compared to its average volume of 559,875. The stock's fifty day simple moving average is $69.59 and its 200-day simple moving average is $71.93. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a market capitalization of $4.13 billion, a price-to-earnings ratio of 15.76 and a beta of 0.61. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Maximus's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.57 earnings per share. Analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.64%. Maximus's payout ratio is currently 23.86%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.